We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A House committee is asking for a review of the FDA’s progress in ensuring the security of foreign facilities’ supply chains and toughening the agency’s approach to inspections at those facilities. Read More
Another Indian drugmaker is in hot water with the FDA, with Sun Pharma’s Halol, Gujarat, facility earning a warning letter for a lack of sterility assurance and validation of the sterility system. Read More
The proposed transaction would consist of an exchange of Sanofi’s Merial animal health business and Boehringer’s consumer healthcare business. Read More